Knee Arthroscopy for Pain Control
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Nov 20, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a specific type of pain management works for patients undergoing knee arthroscopy, which is a minimally invasive surgery to fix problems in the knee. The study will test two methods of pain control: an injection that targets certain nerves in the knee area and local anesthesia applied during the surgery. Researchers want to see how much pain medication participants need afterward, how well they sleep, and whether there are any complications from the surgery.
To be eligible for this trial, patients must be at least 18 years old and have been recommended for knee arthroscopy. However, individuals who have had previous knee surgery on the same side, have been using strong pain medications frequently, or have certain chronic pain conditions will not be able to participate. The study is not currently recruiting participants, so it’s not yet time to sign up, but it aims to help improve pain management for future knee surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • skeletally mature patients with indications for knee arthroscopy
- Exclusion Criteria:
- • include patients with previous knee surgery on the operative side
- • opioid use within six weeks before surgery that is deemed to be chronic or excessive
- • gabapentin use within six weeks before surgery
- • diagnosis of chronic pain, fibromyalgia, or other somatosensory disorder(s)
- • history of radicular pain or neuropathy in the operative limb
- • patients with cancer
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported